Neuromed signs the largest agreement in Canadian biotech history
Neuromed Pharmaceuticals, a spin-out company led by Dr. Terry Snutch, signs the largest agreement in Canadian biotech history (potentially worth $500 million) with Merck & Co. for painkiller MK-6721. Dr. Snutch was the first scientist in the world to describe the molecular basis for calcium channels in the cardiovascular, endocrine, and nervous systems.